PDCD1 and glioblastoma: However, CXCR4-blockade in combination with anti-PD-1 has been shown to have a synergistic effect in increasing the proportion of IFNγ+ and TNFα+ producing CD4+ and CD8+ T cells in the brains of mice with glioblastoma (48).